Compare eBay Inc (EBAY) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Johnson & Johnson — how do they compare? eBay Inc trades at $112.29 (market cap $49.83B), while Johnson & Johnson trades at $259 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 12.4× eBay Inc's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Johnson & Johnson for 129 Days on average.
| EBAY | JNJ | |
|---|---|---|
Market Cap | $49.83B | $618.09B |
Volume | 2,986,953 | 6,050,983 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $278.43 |
52-Week Low | $79.41 | $186.00 |
Typical Hold Time | 134 Days | 129 Days |
Enterprise Value | $53.65B | $646.37B |
Dividend Yield | 1.11% | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
eBay (EBAY) trades at $107.6, up 0.5% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $117.68 implying upside. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue growth is steady, reaching $11.10B in 2025, supported by strong profitability margins including a net income margin of 18.57% and an impressive ROE of 47.38%.
The outlook is positive, driven by earnings momentum and strategic focus on collectibles and live commerce, but risks include competitive pressures from Amazon's new multi-platform tools and potential volatility from GameStop's significant stake. Investor sentiment is mixed, with nearly equal buy and hold ratings from analysts.
Johnson & Johnson (JNJ) trades at $258.45, up 1.44% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and robust cash flow. Analyst consensus is bullish with a $286.53 price target, though technical indicators show resistance near $260. Recent news highlights pipeline strength including Icotyde's potential $4.5B peak sales.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and competitive pressures. The stock presents value near current levels with 10.7% upside to consensus target, though technical weakness suggests potential near-term consolidation. Long-term growth drivers include oncology portfolio and Ottava surgical system development.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
